首页 | 本学科首页   官方微博 | 高级检索  
     


Screening for Hepatitis B Virus DNA in Serum of Organ Donors and Renal Transplant Recipients
Authors:M.?Miédougé  author-information"  >  author-information__contact u-icon-before"  >  mailto:miedouge.m@chu-toulouse.fr"   title="  miedouge.m@chu-toulouse.fr"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,L.?Rostaing,J.?M.?Mansuy,K.?Sandres-Sauné,F.?Boudet,J.?Izopet
Affiliation:1.Laboratoire de Virologie, H?pital Purpan,CHU Toulouse,Toulouse Cedex 9,France;2.Unité de Transplantation d'Organes, H?pital Rangueil,CHU Toulouse,Toulouse Cedex 9,France;3.Coordination des Prélèvements d'Organes, H?pital Purpan,CHU Toulouse,Toulouse Cedex 9,France
Abstract:In order to determine the impact of screening potential organ donors for hepatitis B virus DNA using a standardized test, the serum of 145 donor candidates was tested. All of the candidates were negative for hepatitis B virus DNA, but the status of one donor was doubtful for hepatitis B virus surface antigen and seven donors tested positive for hepatitis B virus core antibody without hepatitis B virus surface antigen. Nine transplant recipients tested positive for hepatitis B virus surface antibody; they were given kidneys from the donor with a doubtful hepatitis B virus surface antigen result and from four of the seven donors who tested positive for hepatitis B core antibody. Follow-up revealed no case of hepatitis B transmission. In this study, screening for hepatitis B virus DNA was useful and did not lead to donor organ shortage. Patients with hepatitis B virus surface antibodies can safely be given kidneys from donors who are positive for hepatitis B core antibody but negative for hepatitis B virus DNA. Electronic Publication
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号